|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Depreciation expense | |||||
| Amortization of intangible assets | |||||
| Loss on impairment of intangible asset and goodwill | |||||
| Impairment of long-lived assets | |||||
| Gain on extinguishment of debt, net | |||||
| Gain on disposal of assets, net | |||||
| Depreciation and amortization | |||||
| (Gain) loss on fair value adjustment of convertible debt | |||||
| Non-cash accrued interest expense | |||||
| Stock compensation expense - stock options | |||||
| Bad debt expense | |||||
| Provision for inventory excess and obsolescence | |||||
| Deferred income tax | |||||
| Amortization of deferred interest | |||||
| Deferred offering costs | |||||
| Other noncash items | |||||
| Accounts and other receivables | |||||
| Inventory | |||||
| Stock compensation expense – common stock | |||||
| Changes in assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Debt | |||||
| Other | |||||
| Due to Affiliates | |||||
| Post employment benefits | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of capital assets | |||||
| Net proceeds from sale of fixed assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible debt | |||||
| Proceeds from promissory note issued by Reshape | |||||
| Proceeds from sale of common stock pursuant to ATM | |||||
| Proceeds from sale of common stock under Concurrent Financing, net of costs of $100,000 and deferred offering costs of $111,415 | |||||
| Advance from affiliates | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
| Supplemental non-cash and financing activities: | |||||
| Cash paid for income taxes | |||||
| Shares issued in settlement of liability to vendor | |||||
| Exchange of accrued fees to director for stock options | |||||
| Exchange of accrued compensation for stock options | |||||
| Incremental fair value of exchange of VTI preferred shares for new series of VTI preferred shares | |||||
| Conversion of preferred shares of VTI to common stock of VTI | |||||
| Net liabilities assumed upon Merger with Reshape | |||||
| Reclassification of debt and equity accounts to non-controlling interests | |||||
| Conversion of debt into common stock | |||||
| Fair value of issuance of warrants to preferred shareholders | |||||
| Reclass of deferred offering costs to additional paid in capital | |||||
| Exchange of entitlement shares for common shares of VHI | |||||
Loading...